We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.25 | 10.00 | 10.50 | 10.25 | 10.25 | 10.25 | 239,636 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.95 | 95.1M |
TIDMSCLP
RNS Number : 7114F
Scancell Holdings Plc
19 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Scancell Holdings plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- --------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ -------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ -------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ -------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ -------------------------------- Other (please specify): ---------------------------------------------------------- -------------------------------- 3. Full name of person(s) Calculus Capital Limited subject to the notification obligation: (iii) ----------------------------------------------------------- --------------------------------- 4. Full name of shareholder(s) Reyker Nominees/Investec Wealth (if different from 3.):(iv) and Investment ----------------------------------------------------------- --------------------------------- 5. Date of the transaction 11 May 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- --------------------------------- 6. Date on which issuer 19 May 2017 notified: ----------------------------------------------------------- --------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 18%,17%,16% ----------------------------------------------------------- --------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------- ---------------- ----------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------- -------------- --------- ------------ ------------ ----------- Ordinary Shares ISIN: GB00B63D3314 49,203,353 49,203,353 50,203,353 50,203,353 15.3% ---------------- ----------------- -------------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- --------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- --------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- -------------- --------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 50,203,353 15.3% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------- N/A Proxy Voting: ---------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------- ------------------------- 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------------------------- ------------------------- 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------------------------- ------------------------- 13. Additional information: N/A ------------------------------------------------------- ------------------------- 14. Contact name: Calculus Capital Limited ------------------------------------------------------- ------------------------- 15. Contact telephone number: 0207 493 4940 ------------------------------------------------------- -------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFSVEEIALID
(END) Dow Jones Newswires
May 19, 2017 09:47 ET (13:47 GMT)
1 Year Scancell Chart |
1 Month Scancell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions